Retinitis Pigmentosa Clinical Trial Pipeline Insights Featuring 40+ Companies | DelveInsight
07 mai 2024 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, May 07, 2024 (GLOBE NEWSWIRE) -- Retinitis Pigmentosa Clinical Trial Pipeline Insights Featuring 40+ Companies | DelveInsight Retinitis pigmentosa is a genetic disorder characterized...
Retinitis Pigmentosa Pipeline Insight Report 2024: Unveiling New Horizons in Genetic Disorder Therapeutics
27 févr. 2024 11h12 HE
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The global medical community is set to...